Two Sigma Investments’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Two Sigma Investments's LLY Position: Q1 2026 in Review
Two Sigma Investments increased its Eli Lilly (LLY) stake by 394% in Q1 2026, buying an estimated $52.2M and bringing the position to 64,550 shares worth $59.4M. The position accounts for 0.05% of the portfolio, ranked #430.
Two Sigma Investments first reported a position in LLY in Q2 2013 and has held it in 35 quarters since. The position peaked at $249M in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Two Sigma Investments held 64,550 shares of Eli Lilly worth $59.4M as of Q1 2026.
- Two Sigma Investments bought 51,482 Eli Lilly shares in Q1 2026, an estimated $52.2M.
- Eli Lilly made up 0.05% of Two Sigma Investments's portfolio in Q1 2026, its #430 holding.
- Two Sigma Investments first reported a position in Eli Lilly in Q2 2013 and has held it in 35 quarters since.
- Two Sigma Investments's Eli Lilly position peaked at $249M in Q4 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.